This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73428216
rdf:type
wikibase:Item
schema:description
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в грудні 1999 artículu científicu espublizáu n'avientu de 1999 scientific article published on 01 December 1999 article scientifique publié en 1999
p:P577
wds:Q73428216-3EB94D8D-555B-4A3E-9E5C-B538ED4C072A
wdt:P577
1999-12-01T00:00:00Z
p:P2093
wds:Q73428216-11D55DDC-3F12-411B-B511-1F16E7C01BD0 wds:Q73428216-F2413970-326A-4FE3-B29D-B082FF04A8C5 wds:Q73428216-E70EC38C-A369-4AAA-A4C3-20E7483F8AF1 wds:Q73428216-E7ACE10C-48B4-4E11-AF38-A57788DBE143 wds:Q73428216-44DABAE5-E6EC-46A5-BDC4-86BCE8DF9AC7 wds:Q73428216-45CBA0C6-61E8-47EF-8CD1-048AD74FEC8B wds:Q73428216-705D0524-987B-41D5-AD57-3ED6AC3FA3F2 wds:Q73428216-77947800-E6BF-4EE1-B9EF-1A4B58C8C16C wds:Q73428216-AEA1B652-A51A-40F6-956A-BE959988FB65 wds:Q73428216-C6C52C59-A3E6-4B12-96E7-086102F43CB8 wds:Q73428216-98C7DD78-86F1-4B23-919E-2FFB12972C97 wds:Q73428216-2931B739-05DF-4290-8B17-92E9F67209DC
wdt:P2093
Royer D Perrault MP Leroy MC Arzur C Boudib C Day B Girard A Vidal-Obert M Masse M Assens C David C Bégué S
rdfs:label
[Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society] [Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society]
skos:prefLabel
[Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society] [Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society]
schema:name
[Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society] [Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society]
p:P50
wds:Q73428216-8919E0E8-8B8D-49A4-A0EE-630E8B4502BA
wdt:P50
wd:Q56491816
p:P1476
wds:Q73428216-5693A4E7-19B1-4277-BE9F-3585C762DAA0
wdt:P1476
[Quality control of labile blood products. Why and howto properly take a specimen? Labile Blood Products Group of the French Blood Transfusion Society]
p:P304
wds:Q73428216-FB9667E7-B82D-4D27-B4FB-47A7535D0528
wdt:P304
403-408
p:P31
wds:Q73428216-5e343e41-037a-4834-a9cd-4607d8f6fd9c wds:Q73428216-3D2F8FAA-EB2C-449D-8D00-965709CF2756
wdt:P31
wd:Q13442814 wd:Q7318358
p:P698
wds:Q73428216-649AEBE7-BE6A-40AC-97AD-7D56C9FF0D85
wdtn:P698
n9:10666798
wdt:P698
10666798
p:P1433
wds:Q73428216-63B69A8C-123D-4F4D-9377-19835C8B97C0
wdt:P1433
wd:Q15758506
p:P433
wds:Q73428216-63403CAC-A0FD-4B84-9364-6A76D3D5B0F3
p:P478
wds:Q73428216-5564D9AD-B049-42E5-A7C2-98622DE2CA39
wdt:P433
6
wdt:P478
6
p:P356
wds:Q73428216-2FE31239-1D34-4521-940D-93BF589A615D
wdtn:P356
n11:S1246-7820(00)88985-5
wdt:P356
10.1016/S1246-7820(00)88985-5